Paion AG Logo

Paion AG

PA8.DE

(0.8)
Stock Price

0,36 EUR

-92.93% ROA

-369.89% ROE

-0.2x PER

Market Cap.

2.709.497,00 EUR

-693.09% DER

0% Yield

-80.51% NPM

Paion AG Stock Analysis

Paion AG Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Paion AG Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.39x) suggests it's undervalued, making it an attractive opportunity for investors.

2 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

3 ROE

The stock's ROE indicates a negative return (-8.51%) on shareholders' equity, suggesting poor financial performance.

4 ROA

The stock's ROA (-3.11%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 DER

The stock is burdened with a heavy load of debt (308%), making it financially unstable and potentially risky for investors.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-105) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Paion AG Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Paion AG Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Paion AG Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Paion AG Revenue
Year Revenue Growth
2003 708.715
2004 16.952.217 95.82%
2005 18.796.037 9.81%
2006 0 0%
2007 0 0%
2008 3.166.370 100%
2009 1.533.231 -106.52%
2010 4.474.411 65.73%
2011 3.249.063 -37.71%
2012 26.812.544 87.88%
2013 4.227.829 -534.19%
2014 3.455.824 -22.34%
2015 71.615 -4725.63%
2016 4.261.774 98.32%
2017 5.811.200 26.66%
2018 2.765.900 -110.1%
2019 8.000.000 65.43%
2020 19.655.104 59.3%
2021 7.128.365 -175.73%
2022 33.248.000 78.56%
2023 18.096.000 -83.73%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Paion AG Research and Development Expenses
Year Research and Development Expenses Growth
2003 8.811.814
2004 7.976.423 -10.47%
2005 13.627.205 41.47%
2006 -16.486.560 182.66%
2007 -9.814.010 -67.99%
2008 8.729.336 212.43%
2009 10.586.296 17.54%
2010 9.016.106 -17.42%
2011 11.824.854 23.75%
2012 3.251.400 -263.68%
2013 4.583.415 29.06%
2014 11.799.194 61.15%
2015 29.384.797 59.85%
2016 23.408.396 -25.53%
2017 17.853.506 -31.11%
2018 12.167.169 -46.74%
2019 13.099.393 7.12%
2020 10.288.176 -27.32%
2021 5.248.851 -96.01%
2022 6.485.000 19.06%
2023 2.924.000 -121.79%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Paion AG General and Administrative Expenses
Year General and Administrative Expenses Growth
2003 2.432.244
2004 5.708.189 57.39%
2005 4.852.195 -17.64%
2006 0 0%
2007 0 0%
2008 7.546.305 100%
2009 4.347.508 -73.58%
2010 4.540.115 4.24%
2011 4.814.647 5.7%
2012 4.708.508 -2.25%
2013 3.314.289 -42.07%
2014 3.702.051 10.47%
2015 5.728.974 35.38%
2016 5.128.622 -11.71%
2017 3.827.552 -33.99%
2018 3.407.785 -12.32%
2019 5.022.729 32.15%
2020 7.523.324 33.24%
2021 19.828.153 62.06%
2022 21.198.000 6.46%
2023 17.512.000 -21.05%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Paion AG EBITDA
Year EBITDA Growth
2003 -10.043.589
2004 266.965 3862.14%
2005 -5.403.916 104.94%
2006 25.190.750 121.45%
2007 13.874.530 -81.56%
2008 -12.918.647 207.4%
2009 -12.827.503 -0.71%
2010 -8.067.509 -59%
2011 -6.624.515 -21.78%
2012 18.563.543 135.69%
2013 -2.587.470 817.44%
2014 -11.480.389 77.46%
2015 -34.928.274 67.13%
2016 -23.516.329 -48.53%
2017 -15.522.604 -51.5%
2018 -12.553.480 -23.65%
2019 -9.206.727 -36.35%
2020 1.936.314 575.48%
2021 -18.824.576 110.29%
2022 4.310.000 536.77%
2023 -15.124.000 128.5%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Paion AG Gross Profit
Year Gross Profit Growth
2003 282.957
2004 14.513.425 98.05%
2005 13.941.151 -4.1%
2006 7.251.730 -92.25%
2007 2.978.510 -143.47%
2008 2.385.925 -24.84%
2009 1.482.331 -60.96%
2010 4.454.924 66.73%
2011 3.247.354 -37.19%
2012 26.811.244 87.89%
2013 4.227.829 -534.16%
2014 3.451.675 -22.49%
2015 60.674 -5588.98%
2016 4.261.774 98.58%
2017 5.811.200 26.66%
2018 2.765.900 -110.1%
2019 8.000.000 65.43%
2020 19.655.104 59.3%
2021 4.051.071 -385.18%
2022 31.288.000 87.05%
2023 6.016.000 -420.08%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Paion AG Net Profit
Year Net Profit Growth
2003 -10.864.393
2004 176.081 6270.15%
2005 -4.756.126 103.7%
2006 0 0%
2007 -10.511.650 100%
2008 -12.580.465 16.44%
2009 -13.037.101 3.5%
2010 -9.254.129 -40.88%
2011 -13.683.754 32.37%
2012 16.008.808 185.48%
2013 -2.211.974 823.73%
2014 -9.104.770 75.71%
2015 -28.212.365 67.73%
2016 -20.117.637 -40.24%
2017 -12.093.427 -66.35%
2018 -9.939.411 -21.67%
2019 -7.015.815 -41.67%
2020 2.222.143 415.72%
2021 -21.785.588 110.2%
2022 -579.000 -3662.62%
2023 -17.872.000 96.76%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Paion AG Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2003 -11
2004 0 0%
2005 -3 100%
2006 0 0%
2007 -5 100%
2008 -5 -25%
2009 -4 0%
2010 -3 -33.33%
2011 -4 25%
2012 5 180%
2013 -1 0%
2014 -2 100%
2015 -5 60%
2016 -4 -66.67%
2017 -2 -50%
2018 -2 -100%
2019 -1 0%
2020 0 0%
2021 -3 100%
2022 0 0%
2023 -3 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Paion AG Free Cashflow
Year Free Cashflow Growth
2003 -10.295.745
2004 3.276.145 414.26%
2005 -4.192.511 178.14%
2006 -14.950.860 71.96%
2007 -13.155.570 -13.65%
2008 -4.589.486 -186.65%
2009 -12.616.434 63.62%
2010 -8.188.210 -54.08%
2011 -7.403.242 -10.6%
2012 15.441.376 147.94%
2013 -1.750.868 981.93%
2014 -12.070.635 85.49%
2015 -26.320.114 54.14%
2016 -11.785.201 -123.33%
2017 -17.745.425 33.59%
2018 -12.825.946 -38.36%
2019 -2.862.192 -348.12%
2020 892.443 420.71%
2021 -40.383.964 102.21%
2022 4.355.000 1027.3%
2023 -2.941.500 248.05%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Paion AG Operating Cashflow
Year Operating Cashflow Growth
2003 -9.567.072
2004 4.997.626 291.43%
2005 -3.744.699 233.46%
2006 -14.950.860 74.95%
2007 -13.155.570 -13.65%
2008 -4.589.486 -186.65%
2009 -12.508.223 63.31%
2010 -8.143.819 -53.59%
2011 -7.358.141 -10.68%
2012 15.475.234 147.55%
2013 -1.745.629 986.51%
2014 -12.044.165 85.51%
2015 -26.286.637 54.18%
2016 -11.586.337 -126.88%
2017 -17.720.444 34.62%
2018 -12.812.878 -38.3%
2019 -2.846.928 -350.06%
2020 906.126 414.19%
2021 -21.178.517 104.28%
2022 5.941.000 456.48%
2023 -2.941.500 301.97%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Paion AG Capital Expenditure
Year Capital Expenditure Growth
2003 728.673
2004 1.721.480 57.67%
2005 447.811 -284.42%
2006 0 0%
2007 0 0%
2008 0 0%
2009 108.211 100%
2010 44.391 -143.77%
2011 45.101 1.57%
2012 33.858 -33.2%
2013 5.239 -546.39%
2014 26.470 80.21%
2015 33.477 20.93%
2016 198.864 83.17%
2017 24.981 -696.06%
2018 13.068 -91.16%
2019 15.264 14.39%
2020 13.682 -11.56%
2021 19.205.448 99.93%
2022 1.586.000 -1110.94%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Paion AG Equity
Year Equity Growth
2003 7.579.251
2004 15.311.974 50.5%
2005 52.750.342 70.97%
2006 45.471.120 -16.01%
2007 35.664.210 -27.5%
2008 31.527.779 -13.12%
2009 19.304.397 -63.32%
2010 11.968.399 -61.29%
2011 -463.666 2681.25%
2012 15.572.131 102.98%
2013 13.329.160 -16.83%
2014 62.607.183 78.71%
2015 35.561.831 -76.05%
2016 24.943.123 -42.57%
2017 25.229.175 1.13%
2018 20.822.042 -21.17%
2019 14.732.497 -41.33%
2020 21.289.826 30.8%
2021 6.999.086 -204.18%
2022 6.615.000 -5.81%
2023 -3.066.000 315.75%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Paion AG Assets
Year Assets Growth
2003 10.002.820
2004 25.670.294 61.03%
2005 66.152.610 61.2%
2006 70.050.232 5.56%
2007 45.541.992 -53.81%
2008 49.313.196 7.65%
2009 35.549.961 -38.72%
2010 26.835.612 -32.47%
2011 12.606.112 -112.88%
2012 28.335.890 55.51%
2013 18.015.787 -57.28%
2014 66.548.153 72.93%
2015 43.467.906 -53.1%
2016 37.983.552 -14.44%
2017 31.885.368 -19.13%
2018 24.323.413 -31.09%
2019 24.911.826 2.36%
2020 28.149.817 11.5%
2021 36.784.666 23.47%
2022 38.177.000 3.65%
2023 32.237.000 -18.43%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Paion AG Liabilities
Year Liabilities Growth
2003 2.423.569
2004 10.358.320 76.6%
2005 13.402.268 22.71%
2006 24.579.112 45.47%
2007 9.877.782 -148.83%
2008 17.785.417 44.46%
2009 16.245.564 -9.48%
2010 14.867.212 -9.27%
2011 13.069.779 -13.75%
2012 12.763.759 -2.4%
2013 4.686.627 -172.34%
2014 3.940.970 -18.92%
2015 7.906.075 50.15%
2016 13.040.428 39.37%
2017 6.656.193 -95.91%
2018 3.501.370 -90.1%
2019 10.179.328 65.6%
2020 6.859.991 -48.39%
2021 29.785.579 76.97%
2022 31.562.000 5.63%
2023 35.303.000 10.6%

Paion AG Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2.19
Net Income per Share
-1.77
Price to Earning Ratio
-0.2x
Price To Sales Ratio
0.17x
POCF Ratio
-0.54
PFCF Ratio
-0.43
Price to Book Ratio
-0.83
EV to Sales
1.24
EV Over EBITDA
-2.58
EV to Operating CashFlow
-4.1
EV to FreeCashFlow
-3.07
Earnings Yield
-4.91
FreeCashFlow Yield
-2.32
Market Cap
0,00 Bil.
Enterprise Value
0,02 Bil.
Graham Number
4.15
Graham NetNet
-3.82

Income Statement Metrics

Net Income per Share
-1.77
Income Quality
0.38
ROE
-3.7
Return On Assets
-0.39
Return On Capital Employed
-0.53
Net Income per EBT
1.03
EBT Per Ebit
1.48
Ebit per Revenue
-0.53
Effective Tax Rate
0.01

Margins

Sales, General, & Administrative to Revenue
0.28
Research & Developement to Revenue
0.2
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.47
Operating Profit Margin
-0.53
Pretax Profit Margin
-0.78
Net Profit Margin
-0.81

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.66
Free CashFlow per Share
-0.89
Capex to Operating CashFlow
0.34
Capex to Revenue
-0.1
Capex to Depreciation
-0.75
Return on Invested Capital
-0.45
Return on Tangible Assets
-0.93
Days Sales Outstanding
43.48
Days Payables Outstanding
482.09
Days of Inventory on Hand
189.93
Receivables Turnover
8.4
Payables Turnover
0.76
Inventory Turnover
1.92
Capex per Share
-0.22

Balance Sheet

Cash per Share
0,66
Book Value per Share
-0,43
Tangible Book Value per Share
-3.08
Shareholders Equity per Share
-0.43
Interest Debt per Share
3.09
Debt to Equity
-6.93
Debt to Assets
0.66
Net Debt to EBITDA
-2.22
Current Ratio
0.76
Tangible Asset Value
-0,02 Bil.
Net Current Asset Value
-0,02 Bil.
Invested Capital
-6.93
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.58
Average Receivables
0,00 Bil.
Average Payables
0,01 Bil.
Average Inventory
2142000
Debt to Market Cap
7.84

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Paion AG Dividends
Year Dividends Growth

Paion AG Profile

About Paion AG

Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. It is also developing Angiotensin II, a vasoconstrictor indicated for the treatment of refractory hypotension in adults with septic or other distributive shock; and Eravacycline, a novel fluorocycline antibiotic indicated for the treatment of complicated intra-abdominal infections in adults. The company has partnerships and license agreements with Cosmo Pharmaceuticals, Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, Hana Pharm, Yichang Humanwell, and Mundipharma. Paion AG was founded in 2000 and is based in Aachen, Germany.

CEO
Mr. Tilmann Bur
Employee
64
Address
Heussstrasse 25
Aachen, 52078

Paion AG Executives & BODs

Paion AG Executives & BODs
# Name Age
1 Ralf Penner
Vice President of Investor Relations & Public Relations
70
2 Mr. Tilmann Bur
Member of Management Board & Chief Executive Officer
70
3 Dr. Thomas Stoehr
Senior Vice President of Development
70
4 Mr. Sebastian Werner
Member of Management Board & Chief Financial Officer
70

Paion AG Competitors